U.S. Markets open in 51 mins
  • S&P Futures

    3,460.75
    +11.50 (+0.33%)
     
  • Dow Futures

    28,352.00
    +84.00 (+0.30%)
     
  • Nasdaq Futures

    11,685.25
    +35.50 (+0.30%)
     
  • Russell 2000 Futures

    1,640.20
    +9.60 (+0.59%)
     
  • Crude Oil

    40.71
    +0.07 (+0.17%)
     
  • Gold

    1,916.90
    +12.30 (+0.65%)
     
  • Silver

    24.94
    +0.24 (+0.96%)
     
  • EUR/USD

    1.1858
    +0.0032 (+0.2727%)
     
  • 10-Yr Bond

    0.8620
    +0.0140 (+1.65%)
     
  • Vix

    27.66
    -0.99 (-3.46%)
     
  • GBP/USD

    1.3099
    +0.0019 (+0.1415%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.1145%)
     
  • BTC-USD

    12,956.69
    -10.04 (-0.08%)
     
  • CMC Crypto 200

    261.65
    +5.55 (+2.17%)
     
  • FTSE 100

    5,873.08
    +87.43 (+1.51%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Shareholders Are Thrilled That The PRA Health Sciences (NASDAQ:PRAH) Share Price Increased 129%

Simply Wall St
·3 mins read

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can see its share price rise well over 100%. For instance, the price of PRA Health Sciences, Inc. (NASDAQ:PRAH) stock is up an impressive 129% over the last five years. It's down 6.8% in the last seven days.

See our latest analysis for PRA Health Sciences

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Over half a decade, PRA Health Sciences managed to grow its earnings per share at 86% a year. The EPS growth is more impressive than the yearly share price gain of 18% over the same period. Therefore, it seems the market has become relatively pessimistic about the company.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
earnings-per-share-growth

We know that PRA Health Sciences has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

A Different Perspective

PRA Health Sciences shareholders are down 1.7% for the year, but the market itself is up 19%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 18% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - PRA Health Sciences has 2 warning signs we think you should be aware of.

We will like PRA Health Sciences better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.